Persistent pain results in suffering and poor quality of life. In addition, the lack of proper control of persistent pain may lead to the development of physical and mental disabilities, which further devastate the patient’s quality of life. The main goal of our research activities is to identify pivotal mechanisms in neuronal processing of information induced by various persistent painful conditions, which could be used to develop new pain killers. Hence, our activities will ultimately improve patients’ quality of life.
Research themes:
Results
- Showing results for:
- Reset all filters
Search results
-
Journal articleRice ASC, Farquhar-Smith WP, Nagy I, 2002,
Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy
, PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, Vol: 66, Pages: 243-256, ISSN: 0952-3278- Author Web Link
- Cite
- Citations: 146
-
Journal articleAhluwalia J, Urban L, Bevan S, et al., 2002,
Cannabinoid 1 receptors are expressed by nerve growth factor- and glial cell-derived neurotrophic factor-responsive primary sensory neurones
, NEUROSCIENCE, Vol: 110, Pages: 747-753, ISSN: 0306-4522- Author Web Link
- Cite
- Citations: 57
-
Journal articleAvelino A, Cruz C, Nagy I, et al., 2002,
Vanilloid receptor 1 expression in the rat urinary tract
, NEUROSCIENCE, Vol: 109, Pages: 787-798, ISSN: 0306-4522- Author Web Link
- Cite
- Citations: 182
-
Journal articleUrban L, Nagy I, Bevan SJ, 2001,
Chronic neuropathic pain: Pathomechanism and pharmacology
, DRUG DEVELOPMENT RESEARCH, Vol: 54, Pages: 159-166, ISSN: 0272-4391- Author Web Link
- Cite
- Citations: 1
-
Journal articleMorisset V, Ahluwalia J, Nagy I, et al., 2001,
Possible mechanisms of cannabinoid-induced antinociception in the spinal cord
, EUROPEAN JOURNAL OF PHARMACOLOGY, Vol: 429, Pages: 93-100, ISSN: 0014-2999- Author Web Link
- Cite
- Citations: 68
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.